TrialThrombosis and haemostasis2015

Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The X-PLORER trial.

P Vranckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.